Shelter Pharma Limited, a publicly listed player in the healthcare and wellness space, has received shareholder approval for a special resolution to issue 91,02,000 convertible equity share warrants on a preferential basis, aggregating up to ₹38.45 crore. The resolution was passed during the Extraordinary General Meeting (EGM) held on July 23, 2025, at the company’s registered office in Himmatnagar, Gujarat.

According to the filing made to BSE (Scrip Code: 543963) on July 24, 2025, the EGM saw a strong participation, with 54.97% of total shareholders’ equity voting on the resolution, and 100% of those votes cast in favour of the proposal.

Key Highlights of the Resolution

• The company will issue 91,02,000 convertible warrants at an issue price of ₹42.25 each, which includes a face value of ₹10 and a premium of ₹32.25 per warrant.

• These warrants are convertible into equity shares on a 1:1 basis at the same price, at the discretion of the allottee.

• The total fund-raising size stands at ₹38,45,59,500.

• The allotment will be made to both promoter group and non-promoter investors.

• The issuance is being carried out under Sections 23(1)(b), 42, and 62(1)(c) of the Companies Act, 2013, as well as in accordance with the SEBI (ICDR) Regulations, 2018, and SEBI (LODR) Regulations, 2015.

Voting Results Breakdown

The resolution saw the following participation:

The voting participation included 6 promoter shareholders and 13 public shareholders attending the meeting in person or through proxy. No shareholders participated via video conferencing.

As per the scrutinizer’s report, the special resolution was deemed passed, since votes cast by non-promoter shareholders in favour of the resolution were more than twice the votes cast against it—with zero opposition recorded.

Background and Regulatory Compliance

The voting was conducted under the scrutiny of CS Murtuza Mandorwala (FCS 10745) of Murtuza Mandorwala & Associates, appointed by the board on June 26, 2025. His final report was issued on July 23, 2025, the same day as the EGM.

Record date for eligibility to vote was July 17, 2025, with 1,121 shareholders on record.

The move by Shelter Pharma to raise capital through a preferential issue aligns with standard fund-raising strategies employed by listed companies for business expansion, R&D, or strategic investments. The company has ensured full compliance with SEBI’s preferential issue norms, Companies Act requirements, and LODR obligations, as disclosed in the official filing.

About Shelter Pharma Limited

Shelter Pharma Limited is engaged in the manufacture and distribution of Ayurvedic and herbal formulations, focused on promoting health and happiness through time-tested natural remedies. With a manufacturing base in Himatnagar, Gujarat, and a corporate office in Ahmedabad, the company has carved out a niche in the Indian herbal healthcare market.

It offers products across therapeutic areas such as digestive health, respiratory care, liver support, and general wellness. The company’s equity shares are currently listed only on BSE, under ISIN INE013V01011.

Final Word

With shareholder approval now secured, Shelter Pharma is expected to proceed with the allotment of warrants, followed by conversion into equity shares as per applicable SEBI timelines. This capital infusion will potentially strengthen the company’s balance sheet and support its long-term growth plans in the Indian wellness and pharmaceutical sector.

The successful passage of the special resolution demonstrates shareholder confidence in the company’s strategic direction and its commitment to regulatory transparency.

The Upcoming IPOs in this week and coming weeks are Takyon Networks, Mehul Colours, Aditya Infotech, Sri Lotus Developers & Realty, Lakshmi India Finance, Jyoti Global Plast, B.D. Industries (Pune), Kaytex Fabrics, Umiya Mobile, Shree Refrigerations, Sellowrap Industries, Repono, Shanti Gold International, Patel Chem Specialities, NSDL.

The Current active IPO are Brigade Hotel Ventures, Indiqube Spaces, GNG Electronics, TSC India, Monarch Surveyors & Engineering Consultants.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.